| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |